Literature DB >> 26375660

Creutzfeldt-Jakob Disease-Like Periodic Sharp Wave Complexes in Voltage-Gated Potassium Channel-Complex Antibodies Encephalitis: A Case Report.

Martin Savard1, Sarosh R Irani, Annie Guillemette, Stéphanie Gosselin-Lefebvre, Michael Geschwind, Gerard H Jansen, Peter V Gould, Robert Laforce.   

Abstract

INTRODUCTION: Voltage-gated potassium channel-complex antibodies (VGKC-cAbs) encephalitis, a treatable autoantibody encephalopathy, has been previously reported to clinically mimic sporadic Creutzfeldt-Jakob disease. Among available clinical clues to distinguish them, periodic sharp wave complexes, a typical finding in sporadic Creutzfeldt-Jakob disease, have never been reported in association with VGKC-cAbs encephalitis. CASE
PRESENTATION: A 76-year-old man was transferred to a tertiary neurology center with a clinical history of 6-month weight loss, cognitive disturbance, and nonspecific generalized weakness. He had two seizures the month before transfer and then evolved to severe encephalopathy, requiring mechanical ventilation. Periodic sharp wave complexes every 1 to 2 seconds over slowed background were found on EEG, and MRI showed cerebellar and bifrontal cortical T2/FLAIR/DWI hypersignal without restricted diffusion on ADC mapping. Pancorporal positron emission tomography scan was negative. An immunotherapy trial did not improve the patient condition. Therefore, he died after life support withdrawal. Brain autopsy revealed mononuclear neocortex infiltrate without significant spongiosis, and the anti-VGKC test showed a seropositivity of 336 pmol/L (normal, 0-31), 3 month after the patient deceased.
CONCLUSIONS: This is the first reported case of VGKC-cAbs encephalitis associated with periodic sharp wave complexes on EEG, which further confuse the differential diagnosis with sporadic Creutzfeldt-Jakob disease. However, the cortical DWI hypersignal without restriction seems to remain a way to discriminate these two entities appropriately, when present. These clues are of paramount importance because VGKC-cAbs encephalitis is a treatable disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26375660      PMCID: PMC4740210          DOI: 10.1097/WNP.0000000000000171

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  15 in total

Review 1.  Emerging pharmacotherapies for Creutzfeldt-Jakob disease.

Authors:  Carsten Korth; Peter J Peters
Journal:  Arch Neurol       Date:  2006-04

2.  Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

Authors:  Christian G Bien; Angela Vincent; Michael H Barnett; Albert J Becker; Ingmar Blümcke; Francesc Graus; Kurt A Jellinger; David E Reuss; Teresa Ribalta; Jürgen Schlegel; Ian Sutton; Hans Lassmann; Jan Bauer
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

3.  Source localization of triphasic waves: implications for the pathophysiological mechanism.

Authors:  Oh-Young Kwon; Ki-Young Jung; Ki-Jong Park; Joong-Koo Kang; Young-Min Shon; Il-Keun Lee; Myung-Kul Yum
Journal:  Clin EEG Neurosci       Date:  2007-07       Impact factor: 1.843

Review 4.  EEG in Creutzfeldt-Jakob disease.

Authors:  Heinz Gregor Wieser; Kaspar Schindler; Dominik Zumsteg
Journal:  Clin Neurophysiol       Date:  2006-01-25       Impact factor: 3.708

5.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

6.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.

Authors:  M J Thieben; V A Lennon; B F Boeve; A J Aksamit; M Keegan; S Vernino
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.

Authors:  Bernhard J Steinhoff; Inga Zerr; Maya Glatting; Walter Schulz-Schaeffer; Sigrid Poser; Hans A Kretzschmar
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

8.  Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.

Authors:  S R Levy; K H Chiappa; C J Burke; R R Young
Journal:  J Clin Neurophysiol       Date:  1986-01       Impact factor: 2.177

9.  Clinical spectrum of voltage-gated potassium channel autoimmunity.

Authors:  K M Tan; V A Lennon; C J Klein; B F Boeve; S J Pittock
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

10.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

Authors:  Angela Vincent; Camilla Buckley; Jonathan M Schott; Ian Baker; Bonnie-Kate Dewar; Niels Detert; Linda Clover; Abigail Parkinson; Christian G Bien; Salah Omer; Bethan Lang; Martin N Rossor; Jackie Palace
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

View more
  3 in total

Review 1.  Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.

Authors:  Mark P Figgie; Brian S Appleby
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

2.  The importance of recognizing faciobrachial dystonic seizures in rapidly progressive dementias.

Authors:  Mateus Mistieri Simabukuro; Paulo Ribeiro Nóbrega; Milena Pitombeira; Wagner Cid Palmeira Cavalcante; Ronnyson Susano Grativvol; Lécio Figueira Pinto; Luiz Henrique Martins Castro; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

Review 3.  Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.

Authors:  Lucas M Ascari; Stephanie C Rocha; Priscila B Gonçalves; Tuane C R G Vieira; Yraima Cordeiro
Journal:  Front Bioeng Biotechnol       Date:  2020-10-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.